![Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial - American Journal of Kidney Diseases Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9333918f-01c5-4635-9745-3241470accd5/gr3.jpg)
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial - American Journal of Kidney Diseases
![Increase in phosphaturia by inhibition of renal sodium-dependent phosphate cotransporter NPT2a - Kidney International Increase in phosphaturia by inhibition of renal sodium-dependent phosphate cotransporter NPT2a - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3b8c2aa7-b32a-4721-bdad-b9f32cb44b9e/gr2_lrg.jpg)
Increase in phosphaturia by inhibition of renal sodium-dependent phosphate cotransporter NPT2a - Kidney International
![Assessment of urinary phosphate excretion in normal and abnormal children. | Archives of Disease in Childhood Assessment of urinary phosphate excretion in normal and abnormal children. | Archives of Disease in Childhood](https://adc.bmj.com/content/41/219/541.extract.jpg)
Assessment of urinary phosphate excretion in normal and abnormal children. | Archives of Disease in Childhood
![Hypophosphatemia: an evidence-based approach to its clinical consequences and management | Nature Reviews Nephrology Hypophosphatemia: an evidence-based approach to its clinical consequences and management | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncpneph0124/MediaObjects/41581_2006_Article_BFncpneph0124_Fig1_HTML.jpg)
Hypophosphatemia: an evidence-based approach to its clinical consequences and management | Nature Reviews Nephrology
The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease | PLOS ONE
![Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium–Phosphate Cotransporter | NEJM Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium–Phosphate Cotransporter | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2002/nejm_2002.347.issue-13/nejmoa020028/production/images/img_medium/nejmoa020028_f3.jpeg)
Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium–Phosphate Cotransporter | NEJM
![Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms | Scientific Reports Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-32065-2/MediaObjects/41598_2018_32065_Fig5_HTML.png)
Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms | Scientific Reports
![Increased serum phosphate concentrations in patients with advanced chronic kidney disease treated with diuretics | Nefrología Increased serum phosphate concentrations in patients with advanced chronic kidney disease treated with diuretics | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251413052901:11872_16025_45503_en_f411872i_02_maquetacin_1.jpg?idApp=UINPBA000064)
Increased serum phosphate concentrations in patients with advanced chronic kidney disease treated with diuretics | Nefrología
![Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review - ScienceDirect Phosphate Absorption and Hyperphosphatemia Management in Kidney Disease: A Physiology-Based Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590059521001825-gr1.jpg)